NFE2L2 and obesity disorder: Therefore, miR-34a-5p tightly modulated the development and progression of lipid accumulation in obesity-related diabetic steatohepatitis, and GA significantly inhibited hepatic lipogenesis by downregulating miR-34a-5p through targeting NFE2L2 in diabetic mice.